86 related articles for article (PubMed ID: 2325263)
1. [Flow cytometric DNA analysis of papillary carcinoma of the thyroid using paraffin-embedded specimens].
Yamashita T; Hirayama A; Obara T; Fujimoto Y; Kodama T; Kenmotsu M; Okuda A
Gan No Rinsho; 1990 Apr; 36(5):569-73. PubMed ID: 2325263
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric DNA content analysis in thyroid carcinoma].
Zuo LF
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear DNA content in small thyroid papillary carcinomas determined by microfluorometry].
Omata K; Naoe S; Tanaka N
Gan No Rinsho; 1987 Feb; 33(2):119-24. PubMed ID: 3560446
[TBL] [Abstract][Full Text] [Related]
5. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
Motomura Y
Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
[TBL] [Abstract][Full Text] [Related]
9. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.
Johannessen JV; Sobrinho-Simões M; Tangen KO; Lindmo T
Lab Invest; 1981 Oct; 45(4):336-41. PubMed ID: 7300245
[TBL] [Abstract][Full Text] [Related]
10. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
12. Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1993; 13(1):267-71. PubMed ID: 8097390
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
14. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
16. Importance of tumour size in papillary and follicular thyroid cancer.
Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
[TBL] [Abstract][Full Text] [Related]
17. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
[TBL] [Abstract][Full Text] [Related]
19. Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant.
Ortiz S; Rodríguez JM; Parrilla P; Pérez D; Moreno-Gallego A; Rios A; Soria T
Eur J Surg; 2001 Jun; 167(6):406-12. PubMed ID: 11471663
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
Johnson TS; Williamson KD; Cramer MM; Peters LJ
Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
